$40.38 -$1.26 (-3.0%)

04:00 PM EDT on 08/22/19

ShockWave Medical (NASDAQ:SWAV)

CAPS Rating: 5 out of 5

Current Price $40.38 Mkt Cap $1.3B
Open $41.82 P/E Ratio 0.00
Prev. Close $41.64 Div. (Yield) -$1.22 (0.0%)
Daily Range $39.54 - $42.00 Volume 153,985
52-Wk Range $24.58 - $68.39 Avg. Daily Vol. 9

Caps

How do you think NASDAQ:SWAV will perform against the market?

Add Stock to CAPS Watchlist

All Players

71 Outperform
0 Underperform
 

All-Star Players

25 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:SWAV Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:SWAV VS S&P 500 (SPY)

NASDAQ:SWAV Summary

Fools bullish on NASDAQ:SWAV are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about SWAV.

Recs

0
Member Avatar MaestroFool (84.80) Submitted: 8/21/2019 4:17:38 PM : Outperform Start Price: $41.82 NASDAQ:SWAV Score: -3.14

Shockwave's technology really sounds revolutionary and has the potential to transform how cardiologists treat their patients, and therefore has a huge market opportunity. Could be like buying Intuitive Surgical decades ago. Outperform.

Recs

0
Member Avatar AverySmith (50.58) Submitted: 8/14/2019 6:54:21 AM : Outperform Start Price: $42.53 NASDAQ:SWAV Score: -6.54

Shockwave Medical is a small biotech company that is changing the way the world treats coronary artery disease; the build-up of calcified lesions in the arteries. Cardiovascular disease is the number one cause of death, claiming 31% of deaths globally each year, and calcifiction of the arteries is often the cause. If Shockwave's lithotripsy inspired treatment gains traction globally there will be a huge upside for its stock, even if it only claims a small slice of the 800 billion dollars spent annually on cardiovascular health.

For these reasons I expect Shockwave medical to outperform the healthcare sector and the S&P 500 over the next 5 years.

Disclaimer: I own shares of and recommend Shockwave Medical: SWAV

Kind regards,
Avery Pemberton-Smith

Recs

0
Member Avatar dmosd (< 20) Submitted: 7/21/2019 3:37:51 PM : Outperform Start Price: $50.01 NASDAQ:SWAV Score: -17.49

I love the concept and the fact that there is still a wide open market

Leaderboard

Find the members with the highest scoring picks in SWAV.

Score Leader

letsgo12

letsgo12 (42.12) Score: +10.49

The Score Leader is the player with the highest score across all their picks in SWAV.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
raderoch 72.50 8/22/2019 Outperform 5Y $40.38 0% -0.15% +0.15 0 Comment
bonjourmesamis 76.04 5/2/2019 Outperform 5Y $40.66 -0.69% +0.24% -0.93 0 Comment
clickme999 87.44 5/2/2019 Outperform 5Y $40.66 -0.69% +0.24% -0.93 0 Comment
usubanas2 96.80 5/2/2019 Outperform 5Y $40.66 -0.69% +0.24% -0.93 0 Comment
SoMuchMass 79.70 5/2/2019 Outperform 5Y $40.66 -0.69% +0.24% -0.93 0 Comment
williams3 83.31 5/2/2019 Outperform 5Y $40.66 -0.69% +0.24% -0.93 0 Comment
Mkot < 20 5/2/2019 Outperform 5Y $40.66 -0.69% +0.24% -0.93 0 Comment
COS47 49.65 5/2/2019 Outperform 5Y $40.66 -0.69% +0.24% -0.93 1 Comment
MEExpat 72.07 5/2/2019 Outperform 5Y $40.66 -0.69% +0.24% -0.93 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. MXL813SA 46.31 5/2/2019 Outperform 5Y $40.66 -0.69% +0.24% -0.93 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SWAV.